Item Infomation


Title: 
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
Authors: 
Marius, Trøseid
José R., Arribas
Lambert, Assoumou
Issue Date: 
2023
Publisher: 
Springer
Abstract: 
Baricitinib has shown efficacy in hospitalized patients with COVID-19, but no placebo-controlled trials have focused specifically on severe/critical COVID, including vaccinated participants.
Description: 
CC BY
URI: 
https://link.springer.com/article/10.1186/s13054-022-04205-8
https://dlib.phenikaa-uni.edu.vn/handle/PNK/7298
Appears in Collections
OER- Y học- Điều dưỡng
ABSTRACTS VIEWS

4

FULLTEXT VIEWS

78

Files in This Item: